2022
Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool
Leone JP, Graham N, Tolaney SM, Leone BA, Freedman RA, Hassett MJ, Leone J, Vallejo CT, Winer EP, Lin NU, Tayob N. Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool. European Journal Of Cancer 2022, 173: 20-29. PMID: 35841843, DOI: 10.1016/j.ejca.2022.06.029.Peer-Reviewed Original ResearchConceptsBreast cancer-specific mortalityHR-positive breast cancerBreast cancerCumulative riskCause mortalityTumor characteristicsRisk of BCSMHormone receptor-positive breast cancerReceptor-positive breast cancerCancer-specific mortalityEnd Results registryLong-term mortalityRisk of deathCancer patient subgroupsPopulation-based riskPathologic variablesInitial diagnosisPatient subgroupsSEER dataPatientsAge groupsCancerMortalityHormone receptorsDiagnosis
2011
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Research And Treatment 2011, 131: 1061-1066. PMID: 22080245, DOI: 10.1007/s10549-011-1872-9.Peer-Reviewed Original ResearchConceptsBasal-like carcinomasBreast cancerPathologic featuresYoung womenPatient ageTumor stageMolecular phenotypesInvasive breast cancerLuminal B tumorsPoor prognostic featuresDifferent age groupsClinical characteristicsB tumorsReceptor statusPrognostic featuresCentral reviewMedical recordsTumor gradeHigh prevalenceLarge cohortGeneral populationAge groupsBiomarker expressionCancerHER2
2005
Adjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer
Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L, B F. Adjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer. JAMA 2005, 293: 1073-1081. PMID: 15741529, DOI: 10.1001/jama.293.9.1073.Peer-Reviewed Original ResearchConceptsLymph node-positive breast cancerNode-positive breast cancerTreatment-related mortalityDisease-free survivalAdjuvant chemotherapyBreast cancerOverall survivalOlder womenMore chemotherapyOlder patientsHigh treatment-related mortalityAge groupsYoung womenPositive lymph nodesHealthy older patientsDuration of chemotherapyGood general healthSmaller tumor sizeBreast cancer mortalityBreast cancer patientsCommunity medical centerDifferent age groupsTamoxifen useLymph nodesRetrospective review
1997
Breast Cancer
Chu L, Winer E. Breast Cancer. 1997, 257-279. DOI: 10.1007/978-1-4757-2705-0_20.Peer-Reviewed Original ResearchBreast cancerOlder womenMost randomized studiesBreast cancer increasesWomen 65 yearsTreatment of patientsYears of ageOlder patientsRandomized studyIndolent diseaseCancer increasesFunctional statusGeriatric populationRelative survivalTumor biologyAge groupsCancerFemale populationYoung womenCommon diseaseWomenPatientsAgeDiseaseSocial support